Revenue grew 35.30 percent in the second quarter. Axon Enterprise stock costs EUR 371.70 on October

State of Alaska Department of Revenue grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 7,382.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 590,965 shares of the biotechnology company

RDA Financial Network lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 807.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 32,339 shares of the biotechnology company

Purus Wealth Management LLC boosted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 499.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,274 shares of the biotechnology company

The VA added over 1,600 TASER 10 devices to begin equipping police at medical centers; this year's camera and license additions include translation tools.

Nvwm LLC boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 99,266.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,981 shares of the biotechn

Covenant Asset Management LLC purchased a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 13,108 shares of the biotechnology company

Hudock Inc. lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2,640.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,444 shares of the biotechnology company

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Western Financial Corp CA purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 15,953 shares of the biotechnology company

Triumph Capital Management grew its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 4,592.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,906 shares of the biotechnolo